Financials in USD. Standardized financial statements.
A compact view of how Mednow Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Revenue? | $16.64M | $414,000 | $0 |
| Revenue Growth? | +3919.0% | 0.0% | 0.0% |
| Cost of Revenue? | $13.86M | $0 | $0 |
| Gross Profit? | $2.78M | $414,000 | $0 |
| Gross Margin? | +16.7% | +100.0% | 0.0% |
| Operating Expenses? | $22.47M | $9.21M | $469,502 |
| Operating Income? | -$19.69M | -$8.80M | -$469,502 |
| EBITDA? | -$20.87M | -$8.97M | -$263,205 |
| Income Before Tax | -$30.07M | -$8.95M | -$469,502 |
| Income Tax Expense | -$515,960 | $0 | $0 |
| Net Income? | -$29.48M | -$8.95M | -$469,502 |
| EPS? | $-1.37 | $-0.49 | $-0.02 |
| Diluted EPS? | $-1.37 | $-0.49 | $-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality